Our clinical experiences of 6 gastroenteropancreatic neuroendocrine tumor (GEP NETs) patients with recurrent liver metastases

被引:0
|
作者
Nakamura, Shoko [1 ]
Tomisato, Kota [1 ]
Teramoto, Akira [1 ]
Kondo, Akiyuki [1 ]
Matsukawa, Shinobu [1 ]
Yabutani, Akira [1 ]
Iraha, Atsushi [1 ]
Kobashikawa, Kasen [1 ]
Nakamura, Masamoto [1 ]
Nakayoshi, Tomokuni [1 ]
Uchima, Nobufumi [1 ]
Kinjo, Fukunori [1 ]
机构
[1] Urasoe Gen Hosp, Urasoe City, Japan
关键词
neuroendocrine tumor; liver metastases;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P-623
引用
收藏
页码:258 / 258
页数:1
相关论文
共 50 条
  • [41] Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in Precision-Medicine Era
    Kim, S.
    Yoo, K.
    Jung, K.
    Lee, S.
    Lee, J.
    Park, S.
    Park, J.
    Lim, H.
    Kang, W.
    Park, Y.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 85 - 86
  • [42] Clinical manifestation of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in patients with multiple endocrine neoplasia type 1 (MEN-1): case series in NTUH
    Tsai, C. L.
    Cheng, T. Y.
    Tseng, Z. M.
    Chen, P. L.
    Shi, X. R.
    Wang, H. P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 245 - 245
  • [43] Increased Tumor Size and Progression Free Survival after 177Lu-DOTATATE for Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS)
    Patel, J.
    Zhang, K.
    Gbolahan, O. B.
    Schuster, D. M.
    Muzahir, S.
    Patel, P. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E477 - E478
  • [44] Treatment patterns and clinical outcomes of patients with metastatic gastroenteropancreatic neuroendocrine tumors (mGEP-NETs).
    Jiao, Xiaolong
    Pulgar, Sonia J.
    Boyd, Marley
    Braiteh, Fadi S.
    Lowenthal, Susan Pitman
    Cox, David
    Fox, Patricia S.
    Paulson, Andrew Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [46] Impact of primary tumor resection and metastasectomy among gastroenteropancreatic neuroendocrine tumors with liver metastases only on survival
    Chen, Q.
    Li, K.
    Rhodin, K. E.
    Bartholomew, A. J.
    Lidsky, M. E.
    Wei, Q.
    Cai, J.
    Luo, S.
    Zhao, H.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 69 - 69
  • [47] Treatment patterns and clinical outcomes of patients with metastatic gastroenteropancreatic neuroendocrine tumors (mGEP-NETs).
    Jiao, Xiaolong
    Pulgar, Sonia J.
    Boyd, Marley
    Braiteh, Fadi S.
    Lowenthal, Susan Pitman
    Cox, David
    Fox, Patricia S.
    Paulson, Andrew Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] The CLARINET Study - Assessing the Effect of Lanreotide Autogel on Tumor Progression-Free Survival in Patients with Non-Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
    Joelle, Blumberg
    Nilani, Liyanage
    Martyn, Caplin
    PANCREAS, 2012, 41 (02) : 343 - 343
  • [49] A RETROSPECTIVE REAL-WORLD EVIDENCE STUDY OF PATIENTS WITH GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETS) IN THE US USING THE OPTUM DATABASE
    Kunz, P.
    Honeycutt, H.
    Ward, P.
    Dasari, A.
    VALUE IN HEALTH, 2021, 24 : S64 - S64
  • [50] Optimizing the management of patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs): initiation of an octreotide LAR nurse home injection programme in Sweden
    Gustafsson, P.
    Grindberg, S.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2010, 14 : S39 - S39